Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME.
Garrett JK, et al. Among authors: rothenberg me.
J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12.
J Allergy Clin Immunol. 2004.
PMID: 14699394
Clinical Trial.